(Q48636782)

13 February 2018

title

Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease (English)

1 reference

13 February 2018

0 references

0 references

Song H

1

1 reference

13 February 2018

Saito K

2

1 reference

13 February 2018

Seishima M

3

1 reference

13 February 2018

Noma A

4

1 reference

13 February 2018

Urakami K

5

1 reference

13 February 2018

Nakashima K

6

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

13 February 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

13 February 2018

volume

231

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

175-178

1 reference

13 February 2018

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Immunohistochemical localization of apolipoprotein E in human glial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Apolipoprotein E polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Apolipoproteins in human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

The genetic defect causing familial Alzheimer's disease maps on chromosome 21.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Dementia of the Alzheimer Type

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Cu, Zn superoxide dismutase in patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900558-2

7 January 2021

10.1016/S0304-3940(97)00558-2

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018